Literature DB >> 9674635

Effects of gonadal steroids and their antagonists on DNA synthesis in human vascular cells.

D Somjen1, F Kohen, A Jaffe, Y Amir-Zaltsman, E Knoll, N Stern.   

Abstract

The cardiovascular effect of estrogen is currently under intense investigation, but the role of androgens in vascular biology has attracted little attention. Because endothelial repair and vascular smooth muscle cell (VSMC) proliferation affect atherogenesis, we analyzed the effects of 17beta-estradiol (E2), dihydrotestosterone (DHT), and sex hormone antagonists on DNA synthesis in human umbilical VSMCs and in E304 cells (a human umbilical endothelial cell line). In VSMCs, both E2 and DHT had a biphasic effect on [3H]thymidine incorporation into DNA: low concentrations (0.3 nmol/L for E2, 3 nmol/L for DHT) stimulated [3H]thymidine incorporation (+35% and +41%, respectively), whereas high concentrations (30 nmol/L for E2, 300 nmol/L for DHT) inhibited [3H]thymidine incorporation (-40%). In contrast, E2 (0.3 to 300 nmol/L) and DHT (3 to 3000 nmol/L) dose-dependently enhanced [3H]thymidine incorporation in E304 cells (peak, +85% for both). In VSMCs, high concentrations of E2 and DHT inhibited platelet-derived growth factor (PDGF)-or insulin-like growth factor (IGF-1)-induced DNA synthesis (-50% to 80%), whereas PDGF- or IGF-1-dependent DNA synthesis in E304 cells was further increased by E2. The antiestrogens tamoxifen and raloxifene mimicked the effects of E2 on DNA synthesis in both VSMCs and E304 cells. However, when coincubated with a stimulatory concentration of E2 (0.3 nmol/L), tamoxifen and raloxifene blocked E2-induced [3H]thymidine incorporation in E304 cells but not in VSMCs. Finally, the androgen antagonist flutamide inhibited the biphasic effects of DHT on VSMCs and blocked the increase in DNA elicited by DHT in E304 cells. The results suggest complex, dose-dependent, and cell-specific interactions of estrogens, androgens, and their respective antagonists in the control of cellular proliferation in the vascular wall. Gonadal steroid-dependent inhibition of VSMC proliferation and stimulation of endothelial replication may contribute to vascular protection and remodeling responses to vascular injury.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9674635     DOI: 10.1161/01.hyp.32.1.39

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  21 in total

1.  Past, present and future of arterial endofibrosis in athletes: a point of view.

Authors:  Pierre Abraham; Philippe Bouyé; Isabelle Quéré; Jean-Michel Chevalier; Jean-Louis Saumet
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

Review 2.  Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses.

Authors:  Laura N Vandenberg; Theo Colborn; Tyrone B Hayes; Jerrold J Heindel; David R Jacobs; Duk-Hee Lee; Toshi Shioda; Ana M Soto; Frederick S vom Saal; Wade V Welshons; R Thomas Zoeller; John Peterson Myers
Journal:  Endocr Rev       Date:  2012-03-14       Impact factor: 19.871

Review 3.  Sex, Gender, and Sex Hormones in Pulmonary Hypertension and Right Ventricular Failure.

Authors:  James Hester; Corey Ventetuolo; Tim Lahm
Journal:  Compr Physiol       Date:  2019-12-18       Impact factor: 9.090

4.  Study of androgen and atherosclerosis in old-age male.

Authors:  Yun-Mei Yang; Xue-Ying Lv; Wei-Dong Huang; Zhe-Rong Xu; Ling-Jiao Wu
Journal:  J Zhejiang Univ Sci B       Date:  2005-09       Impact factor: 3.066

5.  Adiposity, Sex, and Cardiovascular Disease Risk in Children With CKD: A Longitudinal Study of Youth Enrolled in the Chronic Kidney Disease in Children (CKiD) Study.

Authors:  Tammy M Brady; Jennifer Roem; Christopher Cox; Michael F Schneider; Amy C Wilson; Susan L Furth; Bradley A Warady; Mark Mitsnefes
Journal:  Am J Kidney Dis       Date:  2020-05-07       Impact factor: 8.860

Review 6.  Role of androgen and vitamin D receptors in endothelial cells from benign and malignant human prostate.

Authors:  Alejandro S Godoy; Ivy Chung; Viviana P Montecinos; Ralph Buttyan; Candace S Johnson; Gary J Smith
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-04-02       Impact factor: 4.310

7.  Low serum testosterone is associated with atherosclerosis in postmenopausal women undergoing hemodialysis.

Authors:  Nobuaki Shiraki; Ayumu Nakashima; Shigehiro Doi; Juan Jesús Carrero; Naoko Sugiya; Toshinori Ueno; Peter Stenvinkel; Nobuoki Kohno; Takao Masaki
Journal:  Clin Exp Nephrol       Date:  2013-07-26       Impact factor: 2.801

8.  Androgen stimulates endothelial cell proliferation via an androgen receptor/VEGF/cyclin A-mediated mechanism.

Authors:  Jingjing Cai; Yuan Hong; Chunyan Weng; Chen Tan; Julianne Imperato-McGinley; Yuan-Shan Zhu
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-01-21       Impact factor: 4.733

9.  Efficacy and safety of DT56a compared to hormone therapy in Greek post-menopausal women.

Authors:  G Labos; E Trakakis; P Pliatsika; A Augoulea; V Vaggopoulos; G Basios; G Simeonidis; M Creatsa; A Alexandrou; Z Iliodromiti; D Kassanos; I Lambrinoudaki
Journal:  J Endocrinol Invest       Date:  2013-04-08       Impact factor: 4.256

10.  High glucose blocks the effects of estradiol on human vascular cell growth: differential interaction with estradiol and raloxifene.

Authors:  Dalia Somjen; Channing J Paller; Batya Gayer; Fortune Kohen; Esther Knoll; Naftali Stern
Journal:  J Steroid Biochem Mol Biol       Date:  2004-01       Impact factor: 4.292

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.